Sarepta to seek FDA approval for its second Duchenne’s drug by year’s end

Sarepta to seek FDA approval for its second Duchenne’s drug by year’s end

Submitted by admin on March 12, 2018 - 9:37am
Source: 
Stat
News Tags: 
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
golodirsen
Exondys 51
Headline: 
Sarepta to seek FDA approval for its second Duchenne’s drug by year’s end

Do Not Allow Advertisers to Use My Personal information